C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
-
Job growth but record-high diesel prices -- Trump's midterms mixed bag
-
Trump says envoys taking plan to 'end the war' to Moscow, Kyiv
-
Women's NBA comissioner Engelbert to retire at season's end
-
US Football Hall of Fame revamps selection process
-
Luis Enrique extends contract as PSG coach until 2030
-
Judge declares mistrial in case of US woman who killed her children
-
Duplantis pulls out of Diamond League finals
-
Edgar Davids art thief misses sentencing after being 'knocked out by luggage'
-
Defending champ Sabalenka, Pegula lead way into US Open fourth round
-
Pegula rallies to reach US Open fourth round
-
UK hard-right party rallies behind leader after new donation scandal
-
Defending champ Sabalenka leads way into US Open fourth round
-
Nigeria's Dangote refinery looks to raise $1.6 bn in IPO
-
Bayeux Tapestry 'virtually unchanged', UK museum says, after France spots broken threads
-
Portugal extends talks to privatise national carrier TAP
-
More than 120 killed in Yemen's worst clashes in years: sources
-
Brazil great Formiga says 2027 World Cup will 'change players' lives'
-
Germany hunts climate activist suspected of power grid sabotage
-
Job growth, but surging diesel prices - Trump's midterms mixed bag
-
5 EU countries aim to send rejected migrants to 'return hub' by 2027
-
Top seed Sabalenka powers into US Open fourth round
-
Argentina to return Nazi-looted painting to Jewish collector's heir
-
Russia rights group boss fears post-election crackdown
-
Australian Simmons makes NBA comeback with Kings: reports
-
WHO says key warehouse destroyed by attack in Ukraine
-
Two broken threads on Bayeux Tapestry, no major damage: French minister
-
Hesson says Pakistan players used to 'chaos' after shake-up
-
Meloni marks record in power with eye on 2027 elections
-
Bosnian Serb war criminal to be buried Monday, amid EU backlash
-
Israel emptying West Bank refugee camps could be crime against humanity: UN
-
Julio Iglesias faces new abuse complaint
-
Portugal extends talks to privatise airline
-
Walter made improper deal with Magic after buying Dodgers: report
-
CoinRabbit Wins “Best Crypto Lending Platform 2026” Award from International Business Magazine
-
Russia targets security chief's office in daylight Kyiv strike: Zelensky
-
Judge declares mistrial in US infanticide case but puts ruling on hold
-
Moyes voices disappointment with Everton's threadbare squad
-
US midterms begin with chaos over mail-voting crackdown
-
Argentina ordered to return Nazi-looted painting to Jewish collector's heir
-
Russell tops second practice to beat Ferrari and Antonelli in Italy
-
Director Maggie Gyllenhaal ditched AI for Marilyn Monroe film
-
'I love the players we have', insists Arsenal boss Arteta
-
'Winner' Fernandez fundamental to Maresca's Man City rebuild
-
Jury resumes deliberations in case of US mother who killed her three children
-
Song Yadong looks to become China's first male UFC champion after home victory
-
Farage's Reform UK meets under cloud of new donation scandal
-
Russia hits SBU headquarters, Ukraine says security chief's office was target
-
Man Utd in 'good place' despite imperfect squad, says Carrick
-
US shows strong job growth in August in boon to Trump
-
Le Pen party sparks furore with 'turn off tap' to Ukraine call
C2Dx Announces Rebrand to Everis Medical, Marking a New Era of Growth
KALAMAZOO, MI / ACCESS Newswire / May 5, 2025 / C2Dx, a leading medical device company known for acquiring and revitalizing essential, underserved technologies, is proud to announce its rebrand to Everis. This transformation reflects the company's continued commitment to elevating possibilities in healthcare, expanding its focus, and propelling impactful surgical technologies forward.
Founded in 2019 by industry experts, C2Dx was built on the belief that proven medical devices still have untapped potential to serve patients and providers. Now, as Everis, the company embraces a name that evokes endurance (ever), progress (evolving), and energy (life force)-capturing the spirit of continuous innovation and purpose-driven growth.
"Everis represents who we are becoming," said Sarah Hollingsworth, Vice President of Marketing. "We're not only preserving the legacy of essential technologies-we're building their future. Our new identity reflects our mission to redefine what's possible in patient care."
While the name is new, the company's dedication remains unchanged: providing exceptional customer support, trusted solutions, and a relentless focus on enhancing outcomes.
"Our evolution into Everis reflects more than a name change-it's a signal of our long-term growth trajectory," said Kevin McLeod, CEO. "We're actively building a portfolio of transformative technologies, and we see corporate development as a vital path to scale our impact. Whether through strategic partnerships or acquisitions, we're focused on expansion and growth."
Everis will debut its new branding at COSM 2025, inviting physicians to experience what's next.
For more information, visit everismedical.com.
Media Contact:
Sarah Hollingsworth
Vice President of Marketing
Everis Medical
[email protected]
everismedical.com
SOURCE: Everis
View the original press release on ACCESS Newswire
O.Johnson--AMWN
